Cancer cells utilize the programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) pathway to suppress immune cells (including T-cells, B-cells, natural killer cells, lymphocytes, and dendritic cells), leading to poor prognoses in various cancers. The gene discussed is PDCD1; the disease is cancer.